216 related articles for article (PubMed ID: 2427577)
1. Biosynthesis and glycosylation of the human complement regulatory protein decay-accelerating factor.
Lublin DM; Krsek-Staples J; Pangburn MK; Atkinson JP
J Immunol; 1986 Sep; 137(5):1629-35. PubMed ID: 2427577
[TBL] [Abstract][Full Text] [Related]
2. Biosynthesis of the human C3b/C4b receptor during differentiation of the HL-60 cell line. Identification and characterization of a precursor molecule.
Atkinson JP; Jones EA
J Clin Invest; 1984 Nov; 74(5):1649-57. PubMed ID: 6334100
[TBL] [Abstract][Full Text] [Related]
3. Biosynthesis and glycosylation of p150,95 and related leukocyte adhesion proteins.
Miller LJ; Springer TA
J Immunol; 1987 Aug; 139(3):842-7. PubMed ID: 3298434
[TBL] [Abstract][Full Text] [Related]
4. The E3-20.5K membrane protein of subgroup B human adenoviruses contains O-linked and complex N-linked oligosaccharides.
Hawkins LK; Wold WS
Virology; 1995 Jul; 210(2):335-44. PubMed ID: 7618271
[TBL] [Abstract][Full Text] [Related]
5. Biochemical characterization of membrane cofactor protein of the complement system.
Ballard LL; Bora NS; Yu GH; Atkinson JP
J Immunol; 1988 Dec; 141(11):3923-9. PubMed ID: 3053903
[TBL] [Abstract][Full Text] [Related]
6. A study of the xenoantigenicity of neonatal porcine islet-like cell clusters (NPCC) and the efficiency of adenovirus-mediated DAF (CD55) expression.
Omori T; Nishida T; Komoda H; Fumimoto Y; Ito T; Sawa Y; Gao C; Nakatsu S; Shirakura R; Miyagawa S
Xenotransplantation; 2006 Sep; 13(5):455-64. PubMed ID: 16925670
[TBL] [Abstract][Full Text] [Related]
7. N-Glycosylation of the human kappa opioid receptor enhances its stability but slows its trafficking along the biosynthesis pathway.
Li JG; Chen C; Liu-Chen LY
Biochemistry; 2007 Sep; 46(38):10960-70. PubMed ID: 17711303
[TBL] [Abstract][Full Text] [Related]
8. Additional forms of human decay-accelerating factor (DAF).
Seya T; Farries T; Nickells M; Atkinson JP
J Immunol; 1987 Aug; 139(4):1260-7. PubMed ID: 2440950
[TBL] [Abstract][Full Text] [Related]
9. Biosynthesis and glycosylation of the carcinoma-associated antigen recognized by monoclonal antibody KS1/4.
Fernsten PD; Pekny KW; Reisfeld RA; Walker LE
Cancer Res; 1990 Aug; 50(15):4656-63. PubMed ID: 1695123
[TBL] [Abstract][Full Text] [Related]
10. Swainsonine induced modification of N-linked oligosaccharides on human phagocytic cell formyl peptide chemotactic receptors.
Heiman DF; Malech HL
Biomed Pharmacother; 1987; 41(6):278-84. PubMed ID: 2833322
[TBL] [Abstract][Full Text] [Related]
11. Expression of two molecular forms of the complement decay-accelerating factor in the eye and lacrimal gland.
Lass JH; Walter EI; Burris TE; Grossniklaus HE; Roat MI; Skelnik DL; Needham L; Singer M; Medof ME
Invest Ophthalmol Vis Sci; 1990 Jun; 31(6):1136-48. PubMed ID: 1693916
[TBL] [Abstract][Full Text] [Related]
12. Intracellular transport and processing of the Marburg virus surface protein in vertebrate and insect cells.
Becker S; Klenk HD; Mühlberger E
Virology; 1996 Nov; 225(1):145-55. PubMed ID: 8918541
[TBL] [Abstract][Full Text] [Related]
13. Biosynthesis pathway of gp90MEL-14, the mouse lymph node-specific homing receptor.
van de Rijn M; Weissman IL; Siegelman M
J Immunol; 1990 Sep; 145(5):1477-82. PubMed ID: 2166761
[TBL] [Abstract][Full Text] [Related]
14. Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1.
Nickells MW; Alvarez JI; Lublin DM; Atkinson JP
J Immunol; 1994 Jan; 152(2):676-85. PubMed ID: 7506731
[TBL] [Abstract][Full Text] [Related]
15. The biochemical characterization of E2, a T cell surface molecule involved in rosettes.
Aubrit F; Gelin C; Pham D; Raynal B; Bernard A
Eur J Immunol; 1989 Aug; 19(8):1431-6. PubMed ID: 2789140
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for variations in the sensitivity of human decay accelerating factor to phosphatidylinositol-specific phospholipase C cleavage.
Walter EI; Roberts WL; Rosenberry TL; Ratnoff WD; Medof ME
J Immunol; 1990 Feb; 144(3):1030-6. PubMed ID: 1688588
[TBL] [Abstract][Full Text] [Related]
17. Biosynthesis and shedding of epiglycanin: a mucin-type glycoprotein of the mouse TA3Ha mammary carcinoma cell.
Thingstad T; Vos HL; Hilkens J
Biochem J; 2001 Jan; 353(Pt 1):33-40. PubMed ID: 11115396
[TBL] [Abstract][Full Text] [Related]
18. Biosynthetic and structural studies on Thy-1 in a rat neuronal tumor cell line.
Wilkerson LS; Touster O
Arch Biochem Biophys; 1993 Jun; 303(2):238-45. PubMed ID: 8099781
[TBL] [Abstract][Full Text] [Related]
19. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.
Shackelford DA; Strominger JL
J Immunol; 1983 Jan; 130(1):274-82. PubMed ID: 6600184
[TBL] [Abstract][Full Text] [Related]
20. Glycoprotein nature of dopamine D1 receptors in the brain and parathyroid gland.
Jarvie KR; Booth G; Brown EM; Niznik HB
Mol Pharmacol; 1989 Oct; 36(4):566-74. PubMed ID: 2682204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
